New York Life Investment Management LLC decreased its stake in shares of ChampionX Co. (NASDAQ:CHX - Free Report) by 90.6% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 20,175 shares of the company's stock after selling 195,572 shares during the quarter. New York Life Investment Management LLC's holdings in ChampionX were worth $549,000 at the end of the most recent quarter.
Several other institutional investors have also recently made changes to their positions in the stock. Venturi Wealth Management LLC boosted its stake in shares of ChampionX by 1,051.8% during the 4th quarter. Venturi Wealth Management LLC now owns 1,889 shares of the company's stock worth $51,000 after acquiring an additional 1,725 shares during the period. R Squared Ltd bought a new position in shares of ChampionX during the 4th quarter worth approximately $103,000. KBC Group NV boosted its stake in shares of ChampionX by 18.3% during the 3rd quarter. KBC Group NV now owns 5,827 shares of the company's stock worth $176,000 after acquiring an additional 903 shares during the period. Ieq Capital LLC bought a new position in shares of ChampionX during the 4th quarter worth approximately $228,000. Finally, Quantinno Capital Management LP bought a new position in shares of ChampionX during the 3rd quarter worth approximately $265,000. Institutional investors and hedge funds own 98.99% of the company's stock.
Wall Street Analysts Forecast Growth
Separately, Citigroup reduced their price target on ChampionX from $45.00 to $40.00 and set a "buy" rating for the company in a research note on Thursday, November 14th.
Read Our Latest Stock Report on ChampionX
ChampionX Stock Performance
CHX traded up $1.14 during trading on Friday, hitting $29.66. The stock had a trading volume of 2,870,377 shares, compared to its average volume of 3,139,890. The company has a 50 day moving average price of $28.91 and a 200-day moving average price of $29.61. The firm has a market cap of $5.66 billion, a price-to-earnings ratio of 17.98 and a beta of 2.28. ChampionX Co. has a one year low of $25.57 and a one year high of $39.95. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.99 and a quick ratio of 1.36.
ChampionX (NASDAQ:CHX - Get Free Report) last released its quarterly earnings results on Tuesday, February 4th. The company reported $0.50 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.47 by $0.03. ChampionX had a return on equity of 19.84% and a net margin of 8.81%. As a group, research analysts predict that ChampionX Co. will post 1.92 EPS for the current year.
ChampionX Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Friday, April 4th will be issued a $0.095 dividend. The ex-dividend date is Friday, April 4th. This represents a $0.38 annualized dividend and a yield of 1.28%. ChampionX's dividend payout ratio is presently 23.03%.
ChampionX Company Profile
(
Free Report)
ChampionX Corporation provides chemistry solutions, artificial lift systems, and engineered equipment and technologies to oil and gas companies worldwide. The company operates through four segments: Production Chemical Technologies, Production & Automation Technologies, Drilling Technologies, and Reservoir Chemical Technologies.
Read More

Before you consider ChampionX, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ChampionX wasn't on the list.
While ChampionX currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.